Translational Seed Grants Program
Forecasted
Translational Seed Grants Program supports Arizona research teams developing bioscience products and services to address compelling clinical needs and translate bench results into viable patient solutions.
Browse similar grants
Funder: Flinn Foundation
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: $100,000 over 18 months for up to 10 teams; up to three follow-on awards
Summary: Supports Arizona research teams translating bioscience innovations into products and services that address significant clinical needs.
Key Information: PIs must work at an eligible Arizona nonprofit institution and participate in quarterly cohort programming.
Description
The Flinn Foundation’s Translational Seed Grants Program supports research teams developing innovative products or services that address well-defined, compelling clinical needs. It focuses on medical devices and equipment, diagnostics, health-focused technology platforms or delivery processes, and therapeutics and pharmaceuticals. Projects should have significant potential to translate bench results into viable solutions benefiting patients in Arizona and beyond.
Launched in 2013, the program advances Arizona’s Bioscience Roadmap goal to “Accelerate Research into Impact,” increasing the scale, speed, and success of commercialization. A five-year renewal beginning with the 2027 application strengthens alignment with the Foundation’s Bioscience Entrepreneurship Program and emphasizes mentorship and learning. Alongside research funding, teams receive commercialization workshops, expert connections, and opportunities to pursue follow-on support.
